Author

Sonia Albini

InsermORCID 0000-0001-9502-1004Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetics· 1 Molecular Biology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 2 Research Focus:cell type annotation· 1 Assay:CRISPR screen· 1 Research Focus:differential expression· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Abbass JaberiD· 2 shared Isabelle RichardiD· 2 shared Nathalie BourgiD· 2 shared Adeline Miranda· 1 shared Ai Vu HongiD· 1 shared Alan Dorval· 1 shared Auriane Dubois· 1 shared Carinne RoudautiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetics

Abbass JaberORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A Single Lipid Nanoparticle Formulation Enables Delivery of Diverse RNA Therapeutics to Human Muscle Models of Duchenne Muscular Dystrophy

Paola Galbiati, Delphine Leclerc, Margaux Mombled, Ruqayya Khan, Maëlle Ralu, Giorgia Bimbi, Giulia Scalisi, Kamel Mamchaoui, Francesco Saverio Tedesco, Sonia Albini, Mario Amendola

bioRxiv · Jul 29, 2026 · PreprintMolecular Biology

A NEW DYSTROPHIN DEFICIENT RAT MODEL MIRRORING EXON SKIPPING IN PATIENTS WITH DMD EXON 45 DELETIONS

Tao Wang, Cynthia Daoud, Auriane Dubois, Guillaume Corre, Jessica Bellec, Matteo Bovolenta, Louise Philidet, Alan Dorval, Nathalie Bourg, Carinne Roudaut, Sonia Albini, Ganesh Warthi, Abbass Jaber, Isabelle Richard

This paper describes a novel rat model with an exon 45 deletion in the Dmd gene, showing features of DMD and exon skipping, which may inform personalized therapies.

Disease Models & Mechanisms · Jan 1, 2026Peer-reviewedGenetics

Targeting lysosomal damage is a new therapeutic perspective for Duchenne Muscular Dystrophy

Abbass Jaber, Laura Palmieri, Rania Bakour, Elise Lachiver, Ai Vu Hong, Nathalie Bourg, Jérôme Poupiot, Sonia Albini, Daniel Stockholm, Laetitia van Wittenberghe, Adeline Miranda, Nathalie Danièle, Inès Barthélémy, Stéphane Blot, Mai Thao Bui, , David Israeli

This study identifies lysosomal damage as a novel mechanism in Duchenne Muscular Dystrophy and shows that combining trehalose with gene therapy improves outcomes.

bioRxiv · Feb 11, 2025 · PreprintPhysiology